BioSpace News Archive

According to Vision Research Reports, the global pyrogen testing market size was estimated at around USD 1.32 billion in 2023 and it is expected to grow at a CAGR of 8.56% from 2024 to 2033, to reach around USD 3 billion by 2033.

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.

Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the first quarter ended March 31, 2024.

Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced financial and operational results for the quarter ended March 31, 2024.

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024.

Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q2 FY 2024”) and six months (“YTD FY 2024") ended March 31, 2024.

Eyenovia, Inc., a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, announced its financial and operating results for the first quarter ended March 31, 2024.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended March 31, 2024.

CooperCompanies, a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024.

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024.